Ping Jing, Hao Hong-Zheng, Wu Zhen-Qi, Yang Yong-Ju, Yu He-Shan
Medical Laboratory, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110000, Liaoning Province, China.
Department of Endocrinology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110000, Liaoning Province, China.
SLAS Technol. 2024 Dec;29(6):100228. doi: 10.1016/j.slast.2024.100228. Epub 2024 Dec 3.
The purpose of this study was to examine the therapeutic potential of core traditional Chinese medicine (CTCM) in the treatment of diabetic peripheral neuropathy (DPN) through the use of a data-driven approach that combined network pharmacology and data mining. Important components of traditional Chinese medicine (TCM) and the targets that correspond with them were found through the examination of numerous databases and clinical prescriptions. The possible therapeutic pathways were investigated, with an emphasis on the AGE-RAGE pathway that was discovered via network pharmacology analysis. By evaluating histopathological alterations, inflammatory and apoptotic markers, microcirculation, and blood hypercoagulability in a rat model of DPN, the effectiveness of CTCM was confirmed.Through experimental validation in DPN rats, it was shown that CTCM improved histopathology, decreased inflammation and apoptosis, improved microcirculation, and corrected coagulation abnormalities in addition to alleviating neuropathic pain. These studies show the value of data-driven approaches in advancing traditional medicine research for drug development and offer a mechanistic basis for CTCM's therapeutic potential in DPN.
本研究的目的是通过结合网络药理学和数据挖掘的数据驱动方法,探讨核心中药(CTCM)在治疗糖尿病周围神经病变(DPN)方面的治疗潜力。通过对众多数据库和临床处方的研究,发现了中药的重要成分及其对应的靶点。研究了可能的治疗途径,重点是通过网络药理学分析发现的AGE-RAGE途径。通过评估DPN大鼠模型中的组织病理学改变、炎症和凋亡标志物、微循环和血液高凝性,证实了CTCM的有效性。通过对DPN大鼠的实验验证,结果表明CTCM除了缓解神经性疼痛外,还改善了组织病理学,减少了炎症和凋亡,改善了微循环,并纠正了凝血异常。这些研究表明了数据驱动方法在推进传统医学药物研发研究中的价值,并为CTCM在DPN中的治疗潜力提供了机制基础。